Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Hepatitis diagnostic tests industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Technology trends
2.6 Test type trends
2.7 End-use trends
Chapter 3 Hepatitis Diagnostic Tests Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevelance of hepatitis
3.2.1.2 Rise in number of blood donation and transfusion
3.2.1.3 Technological advancements in hepatitis diagnostics
3.2.1.4 Increasing awareness and availability of diagnostic test for hepatitis
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limited access to reliable and low-cost hepatitis diagnostic tests
3.2.2.2 Stringent regulatrory framework
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By technology
3.3.3 By test type
3.3.4 By end use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Pricing analysis, 2022
3.7 Reimbursement scenario
3.8 Technology landscape
3.9 Future market trends
3.10 Value chain analysis
3.11 GAP analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Hepatitis Diagnostic Tests Market Size and Forecast, By Product (USD Million & Units)
5.1 Key trends, by product
5.2 Instruments
5.3 Reagents & Kits
Chapter 6 Hepatitis Diagnostic Tests Market Size and Forecast, By Technology (USD Million)
6.1 Key trends, by technology
6.2 Enzyme-linked immunosorbent assay (ELISA)
6.3 Rapid diagnostic tests (RDTS)
6.4 Polymerase chain reaction (PCR)
6.5 Isothermal nucleic acid amplification test (INAAT)
6.6 Others
Chapter 7 Hepatitis Diagnostic Tests Market Size and Forecast, By Test Type (USD Million)
7.1 Key trends, by test type
7.2 Blood tests
7.2.1 Liver function tests
7.2.2 Immunoassays
7.2.3 Nucleic acid tests
7.3 Imaging test
7.4 Liver biopsy
Chapter 8 Hepatitis Diagnostic Tests Market Size and Forecast, By End-use (USD Million)
8.1 Key trends, by end-use
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Others
Chapter 9 Hepatitis Diagnostic Tests Market Size and Forecast, By Region (USD Million & Units)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Belgium
9.3.8 The Netherlands
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Philippines
9.4.8 Malaysia
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Columbia
9.5.5 Chile
9.5.6 Peru
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Israel
9.6.5 Turkey
9.6.6 Egypt
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Analytik Jena
10.3 Autobio Diagnostics
10.4 Bio-Mérieux
10.5 Danher Corporation
10.6 DiaSorin
10.7 Grifols SA
10.8 Hologic
10.9 MedMira Inc
10.10 Ortho-Clinical Diagnostics
10.11 Qualpro Diagnostics
10.12 Roche Molecular Diagnostics
10.13 Siemens Healthcare
10.14 Sysmex Corporation
